Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?

for the RITERM study group

Research output: Contribution to journalReview articlepeer-review

Fingerprint Dive into the research topics of 'Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?'. Together they form a unique fingerprint.

Medicine & Life Sciences